Pharmaprojects: track pharma R&D, Citeline
By Ian Lloyd
Our world was disrupted at warp speed during 2020. Are you ready to gain a deeper understanding of the year that changed our perceptions of possible?
Building something great: UK’s Global Bioscience Cluster 2016 is the first in an ongoing series of jointly reports from Informa Pharma Intelligence and UK Bioindustry Association (BIA). Trusted by over 3,000 of the world’s leading pharmaceutical companies, CRO’s, med and biotech organizations, and healthcare service providers, Pharma Intelligence delivers vital, accurate, and timely intelligence about the drug development pipeline. Pharma Intelligence tools feature continually updated data, global teams of subject area experts, and comprehensive support that is unparalleled anywhere else in the industry. Use the exclusive data and analysis from Pharma Intelligence for bespoke, fully customized reporting that delivers real, actionable insights.
Established over 25 years ago at the infancy of biotechnology, the BioIndustry Association (BIA) is the trade association for innovative life sciences in the UK. The BIA’s goal is to secure the UK's position as a global hub and as the best location for innovative research and commercialisation, enabling our world-leading research base to deliver healthcare solutions that can truly make a difference to people's lives.
Simply complete the required fields to download this informative report, which provides evidence that in 2016, the U.K. maintained its established position as a leader for European biotech funding, and leads Europe in future drug development, boasting the strongest pipeline of any other nation.
Capture the essential information in this definitive report now.
Getting a demo tailored to your needs is the best way to see how our solutions will help you gain an advantage.
Request live demo now:
Our team is always happy to hear from you. Please call us at:
Have an immediate and specific information need?
Browse and buy from 1000s of analysis and research reports now: